Shinichiro Nakajima, MD, PhD
- 5Articles
- 26.1KReads
- 2009–2020Active
- 25Collaborators
- 76Citations
About
Shinichiro Nakajima, MD, PhD, has published extensively on neuropsychiatric conditions including Alzheimer disease, schizophrenia and schizoaffective disorders, cognition, depression, neurology, and sexual dysfunction. The author’s work addresses topics such as antipsychotic treatment response in Alzheimer disease, predictors of disease progression, dopamine receptor occupancy in schizophrenia, antidepressant dosing strategies, and side effects of selective serotonin reuptake inhibitors. Nakajima’s research spans from 2009 to 2020 and includes collaborations with notable co-authors in the field.
Publications
Early Improvements Predict Treatment Response in Alzheimer's
February 11, 2020
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
